Intervacc AB (FRA:2E9) ROE % Adjusted to Book Value: -89.43% (As of Mar. 2026)


FRA:2E9 Intervacc AB FRA:2E9
68 GF Score
Price €0.10
GF Value €0.08
! 5 Warning Signs
View Full Analysis

What is Intervacc AB ROE % Adjusted to Book Value?

Intervacc AB FRA:2E9 -1.59% 68 ROE % Adjusted to Book Value is -89.43% as of Mar. 2026. GuruFocus rates FRA:2E9 with a GF Score™ of 68/100 and a GF Value™ of €0.08. The stock has 5 warning signs investors should review.

Intervacc AB's ROE % for the quarter that ended in Mar. 2026 was -33.09%. Intervacc AB's PB Ratio for the quarter that ended in Mar. 2026 was 0.37. Intervacc AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -89.43%.

Intervacc AB ROE % Adjusted to Book Value Related Terms

Intervacc AB ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Intervacc AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intervacc AB ROE % Adjusted to Book Value Chart

Intervacc AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.90 -3.71 -19.99 -168.68 -82.00

Intervacc AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -32.11 -33.71 -36.84 -106.26 -89.43

FRA:2E9 vs VRTX, REGN, ALNY: ROE % Adjusted to Book Value Comparison

For the Biotechnology subindustry, Intervacc AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intervacc AB ROE % Adjusted to Book Value vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intervacc AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Intervacc AB's ROE % Adjusted to Book Value falls into.


FRA:2E9
68GF Score
Intervacc AB FRA:2E9
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Intervacc AB ROE % Adjusted to Book Value Calculation

Intervacc AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-37.72% / 0.46
=-82.00%

Intervacc AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-33.09% / 0.37
=-89.43%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -89.43% mean?
Intervacc AB (FRA:2E9) has a ROE % Adjusted to Book Value of -89.43% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Intervacc AB and its competitors.
Is Intervacc AB's ROE % Adjusted to Book Value too high?
Intervacc AB's current ROE % Adjusted to Book Value is -89.43%. Overall, Intervacc AB has a GF Score™ of 68/100, reflecting its overall financial health beyond just this single metric.
How does Intervacc AB's ROE % Adjusted to Book Value compare to VRTX and REGN?
Intervacc AB's ROE % Adjusted to Book Value of -89.43% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Biotechnology company?
A good ROE % Adjusted to Book Value depends on the Biotechnology industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Intervacc AB and its competitors. Intervacc AB's current ROE % Adjusted to Book Value is -89.43%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intervacc AB stock overvalued right now?
Intervacc AB (FRA:2E9) has a current ROE % Adjusted to Book Value of -89.43%. The stock's GF Value™ is €0.08, compared to a current price of €0.10 — trading 23.5% above its estimated fair value. The current ROE % Adjusted to Book Value is -89.43%. Intervacc AB's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Intervacc AB (FRA:2E9), the current ROE % Adjusted to Book Value is -89.43% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Intervacc AB (FRA:2E9) Overvalued in 2026?

Based on GuruFocus' analysis, Intervacc AB stock appears to be overvalued. The current stock price of €0.10 is trading 23.5% above its estimated GF Value™ of €0.08.

Key valuation signals for FRA:2E9:

  • ROE % Adjusted to Book Value: -89.43%
  • GF Value™: €0.08 vs. price of €0.10 (23.5% above fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the FRA:2E9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Intervacc AB Business Description

Other Exchanges IVACC:Sweden
Address Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.
68GF Score

Get the complete analysis for FRA:2E9

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.10
Price
€0.08
GF Value